Spruce Biosciences Stock Alpha and Beta Analysis
| SPRB Stock | USD 0.39 0.01 2.50% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Spruce Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Spruce Biosciences over a specified time horizon. Remember, high Spruce Biosciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Spruce Biosciences' market risk premium analysis include:
Beta (0.16) | Alpha (0.07) | Risk 4.76 | Sharpe Ratio (0.02) | Expected Return (0.08) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Spruce |
Spruce Biosciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Spruce Biosciences market risk premium is the additional return an investor will receive from holding Spruce Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Spruce Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Spruce Biosciences' performance over market.| α | -0.07 | β | -0.16 |
Spruce Biosciences expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Spruce Biosciences' Buy-and-hold return. Our buy-and-hold chart shows how Spruce Biosciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Spruce Biosciences Market Price Analysis
Market price analysis indicators help investors to evaluate how Spruce Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Spruce Biosciences shares will generate the highest return on investment. By understating and applying Spruce Biosciences stock market price indicators, traders can identify Spruce Biosciences position entry and exit signals to maximize returns.
Spruce Biosciences Return and Market Media
The median price of Spruce Biosciences for the period between Thu, Oct 10, 2024 and Wed, Jan 8, 2025 is 0.5 with a coefficient of variation of 12.63. The daily time series for the period is distributed with a sample standard deviation of 0.06, arithmetic mean of 0.49, and mean deviation of 0.05. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Spruce Biosciences, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Reach Out | 10/24/2024 |
2 | Spruce Biosciences Releases Quarterly Earnings Results, Beats Estimates By 0.06 EPS | 11/13/2024 |
3 | ARMISTICE CAPITAL, LLC Acquires New Stake in Spruce Biosciences Inc | 11/15/2024 |
4 | Disposition of 842020 shares by Novo Holdings As of Spruce Biosciences at 0.7684 subject to Rule 16b-3 | 11/22/2024 |
5 | Penny Stock Spruce Biosciences Winds Down Tildacerfont Studies For Rare Genetic Disorder | 12/11/2024 |
6 | Spruce Biosciences Upgraded to Buy Heres Why | 12/13/2024 |
7 | Disposition of 111000 shares by Szwarcberg Javier B. of Spruce Biosciences subject to Rule 16b-3 | 12/16/2024 |
8 | Disposition of 32005 shares by Szwarcberg Javier B. of Spruce Biosciences at 0.3887 subject to Rule 16b-3 | 12/20/2024 |
9 | Spruce Biosciences, Inc. Receives 3.90 Consensus Target Price from Brokerages | 12/31/2024 |
About Spruce Biosciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Spruce or other stocks. Alpha measures the amount that position in Spruce Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Spruce Biosciences Upcoming Company Events
As portrayed in its financial statements, the presentation of Spruce Biosciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Spruce Biosciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Spruce Biosciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Spruce Biosciences. Please utilize our Beneish M Score to check the likelihood of Spruce Biosciences' management manipulating its earnings.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Spruce Biosciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Spruce Biosciences Backtesting, Spruce Biosciences Valuation, Spruce Biosciences Correlation, Spruce Biosciences Hype Analysis, Spruce Biosciences Volatility, Spruce Biosciences History and analyze Spruce Biosciences Performance. For information on how to trade Spruce Stock refer to our How to Trade Spruce Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Spruce Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.